A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
N/A
For patients of advanced NSCLC (non small cell lung cancer) , Individualize...
Status
Recruiting
Location
Cancer Center, Sun Yat-sen University
Start Date
2012-09
Trial ID
NCT01994057
The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib
N/A
Non-interventional, multi-country, multi-centre cohort study based on exist...